Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
AstraZeneca
Julphar
US Department of Justice
McKinsey
Cerilliant
Moodys
Queensland Health

Generated: January 21, 2019

DrugPatentWatch Database Preview

Ferring Company Profile

« Back to Dashboard

Summary for Ferring
International Patents:237
US Patents:24
Tradenames:26
Ingredients:14
NDAs:26
Patent Litigation for Ferring: See patent lawsuits for Ferring

Drugs and US Patents for Ferring

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring ZOMACTON somatropin INJECTABLE;INJECTION 019774-002 Jan 4, 2002 BX RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Ferring FIRMAGON degarelix acetate POWDER;SUBCUTANEOUS 022201-001 Dec 24, 2008 RX Yes No 9,415,085 ➤ Try a Free Trial ➤ Try a Free Trial
Ferring LUTREPULSE KIT gonadorelin acetate INJECTABLE;INJECTION 019687-001 Oct 10, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Ferring

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995 5,047,398 ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 5,674,850 ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 5,763,407 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for FERRING drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Oral Solution 10 mg, 3.5 g, and 12 g ➤ Subscribe 2014-05-21
➤ Subscribe Tablets 650 mg ➤ Subscribe 2011-05-24

Supplementary Protection Certificates for Ferring Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2009000033 Germany ➤ Try a Free Trial PRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217
C/GB09/028 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217
C0037 Belgium ➤ Try a Free Trial PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Chubb
Accenture
Merck
Queensland Health
AstraZeneca
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.